Introduction
Mucus secretion plays a key role in the protection of airways from particles and pathogens.
Submucosal gland cells produce about 95% of the mucus in normal airways (Reid, 1960) . However, excessive mucus secretion is a common pathophysiological characteristic in chronic inflammatory respiratory diseases, such as asthma, COPD, and cystic fibrosis. Excessive mucus secretion obstructs airways and impairs gas exchange. Thus, reduction in mucus secretion and clearing of excess mucus from the airways are beneficial in chronic inflammatory lung diseases (Knowles and Boucher, 2002) .
The main macromolecular component of mucus is mucin, a highly glycosylated protein. MUC5AC and MUC5B are major mucin subtypes secreted in the airways (Hewson, et al., 2004) . Mucin proteins link to each other, forming high molecular weight chains that are packaged within vesicles in mucous gland cells and released by exocytosis upon activation of the cells by a stimulus (Evans and Koo, 2009 ).
The process of mucin release has been shown to be similar to neurotransmitter release at a nerve synapse (Evans and Koo, 2009) . In a review of therapeutic strategies to treat mucus hypersecretion, Rogers and Barnes noted that our understanding of the process of mucus release has provided numerous targets for therapeutic agents to decrease release (Rogers and Barnes, 2006) . One class of drugs listed is the macrolide antibiotics, commonly used to treat respiratory infections and also known to have beneficial effects of decreasing inflammation and mucus secretion (Tamaoki, et al., 2004) .
Macrolide antibiotics, such as erythromycin (EM) and azithromycin (AZM), in addition to their antimicrobial action, are known to be anti-inflammatory and moderate mucus secretion in chronic inflammatory lung diseases (Gorrini, et al., 2001) . Macrolide antibiotics have also been shown to directly reduce the secretion of respiratory glycoconjugate induced by histamine and methacholine from human airway cells in vitro (Goswami, et al., 1990) . Another macrolide, Clarithromycin, has been reported to inhibit MUC5AC production by NCI-H292 cells stimulated with ovalbumin and LPS (Shimizu, et al., 2003) , and has been shown to inhibit mucin secretion in a murine diffuse panbronchiolitis model (Kaneko, JPET #171561 et al., 2003) . Although these studies have shown that macrolide antibiotics reduce mucus release directly, the mechanisms of the direct action are unclear. In this study we focused on the direct action of macrolide antibiotics on SMGC in response to secretagogues, specifically through the mechanism of inhibition of Ca 2+ entry, thereby inhibiting increases in [Ca 2+ ] i and Ca 2+ -mediated responses.
An increase in [Ca 2+ ] i is required for ion channel activities and mucin release stimulated by acetylcholine (ACh), histamine, and adenosine triphosphate (ATP) (Liu and Farley, 2005; Hamada, et al., 1993; Choi, et al., 2005; Liu and Farley, Sr., 2007) . In most non-excitable cells, such as SMGC, membrane receptor activation induces Ca 2+ release from internal stores and Ca 2+ influx through store-operated Ca 2+ channels (SOC) or receptor-operated channels (ROC) (Vig and Kinet, 2007; Takemura and Ohshika, 1991) . It has been shown that in SMGC Ca 2+ influx is important for mucus release to occur (Nagaki, et al., 1994) although the pathway is not well described. In this study, we examined the effects of macrolide antibiotics on mucus secretion, ion channel activity and Ca 2+ influx in swine airway SMGC.
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Methods
Cell preparation
SMGC were prepared according to methods established in our lab (Liu and Farley, 2007) . Swine trachea were obtained from a local abattoir (Wilson Meat Packing, Crystal Springs, MS). Trachea were quickly removed after exsanguination of the swine and placed in ice-cold physiological solution for transportation to the laboratory. The transport solution contained 100 U/ml penicillin, 100 µg / ml streptomycin, and 50 µg / ml kanamycin. The epithelium was scraped with a cell scraper (Corining 3010), and then stripped off the cartilage rings, and digested with 1 mg / ml collagenase IV (Worthington CLS-4, Freehold, NJ), 0.5 mg / ml dithiothreitol, and 0.5 mg / ml bovine albumin (Sigma, St. Louis, MO) in physiological solution for four 90-100 min digestion cycles at 37 o C with new enzyme solution used at each cycle. Only cells collected from digest cycles 3 and 4 were used for experiments. The isolated cells were then mixed with 5 ml fetal bovine serum to stop the enzymatic reaction. The cell mixtures were centrifuged through a discontinuous Percoll gradient (10, 20, 30, 40, and 60%) at 500 × g for 10 min.
SMGC were concentrated at the interface between the 40 and 60% layers, removed, washed, and re-suspended in complete PC-1 medium containing 2 mM GlutaMAX (Invitrogen, Carlsbad, CA), serum substitutes (Cambrex Bio Science Walkersville, Inc., Walkersville, MD), and antibiotics. Cells were plated on glass coverslips (VWR, West Chester, PA) coated with poly-L-lysine (P-4707; Sigma-Aldrich)
for patch clamp and Ca 2+ measurement studies. Cells stored at 4 o C in complete PC-1 media overnight showed no differences in electrophysiological responses to those of freshly isolated cells.
Whole-cell K + and Cl -currents measurement
Patch clamp experiments were performed at 24~25 o C in the whole-cell recording configuration (Liu and Farley, 2007 
Mucus collection and enzyme-linked immunoabsorbant assay (ELISA)
Mucus sample collecting was similar to the previous protocol used in our lab (Dwyer and Farley, 1997 
Statistics
Data are shown as means ± SEM. Differences were examined for statistical significance using one-way ANOVA for more than two groups plus post hoc test (Fisher LSD) and Student's t test between two groups. Paired t test or one-way repeated measures ANOVA was used to compare different
Results
EM induced mucin release but inhibited ACh-induced release from SMGC
As described in the methods, mucin release from freshly isolated SMGC was measured from cells 
EM and AZM activated muscarinic receptors in SMGC
Upon whole-cell formation, voltage-ramp protocols as described in previous studies in our lab (Liu and Farley, 2007) were used to detect ACh-, EM-, or AZM-induced whole-cell K Ca and Cl Ca currents. intracellularly via the patch pipette.
Effects of internal application of AZM on ACh-induced K Ca and Cl Ca currents
The effects of AZM on Ca 2+ dependent ACh-induced currents were measured using the voltage-ramp protocol as above. SMGC were dialyzed with normal internal solution or internal solution containing AZM (10 μ M) (Fig. 5A ) for 5 min prior to application of ACh (10 μ M). As shown in Fig. 5A (left panel)
with normal internal solution in the pipette ACh induces a transient increase in I K and I Cl that peaks within a few seconds and then decays to near baseline in ~200 seconds as noted in Fig. 2 (inter-ramp holding potential of -40 mV). In the presence of 10 µM AZM applied intracellularly there is no significant difference in ACh-induced peak K Ca and Cl Ca currents from control ( Fig. 5B ; p > 0.05). As Fig. 5C shown, the half-times of decay of both K Ca (Fig. 5C , left panel) and Cl Ca currents ( is known to be important during the decay phase of the response to ACh (Liu and Farley, 2007 [Ca 2+ ] i _is reduced to 80 ± 5%, 65.6 ± 3%, and 65.1 ± 6%, respectively ( Fig. 6E ; p < 0.05; compared with pre-treatment status). The rates of decline in the intracellular Ca 2+ are clearly much slower than those observed for removal of extracellular calcium.
In another series of experiments TG in 0 Ca 2+ solution was applied to SMGC, then replaced five minutes later by 0 Ca 2+ solution containing 10 µM atropine alone or 10 µM atropine plus 10 µM of either EM or AZM. Atropine was included to eliminate muscarinic receptor activation by the macrolides. Five minutes later 2 mM calcium was introduced into the above solutions and the magnitude of TG induced calcium entry measured as above. As shown in figure 7A and D, atropine had no effect on the magnitude of the increase in calcium induced by TG when calcium was restored compared to control data in Fig. 6A (atropine group: Δ F (340 / 380) = 0.83 ± 0.08; p > 0.05; compared with control group (Fig. 6A ): Δ F (340 / 380) = 0.82 ± 0.14). Five minute pre-exposure to either 10 µM EM (Fig. 7B) or AZM (Fig. 7C) This article has not been copyedited and formatted. The final version may differ from this version. with atropine alone control as summarized in Fig. 7D .
EM inhibits store depletion-activated current.
The effects of EM on store depletion-induced non-selective cation current was also measured. TG (2 µM) was applied in the external solution and EGTA (10 mM) and 140 nM free Ca 2+ was included in internal solution to deplete calcium stores during whole-cell voltage-clamp to induce NSCC. The magnitude of the NSCC current was 49 ± 11 pA when divalent-free external solution was used ( Fig 
Discussion
Macrolide antibiotics reduce mucus hypersecretion and improve lung function in the treatment of CF and panbrochiolitis (Crosbie and Woodhead, 2009 ) by an effect unrelated to their antibiotic properties.
Several mechanisms have been proposed for inhibition of mucus secretion including: 1) inhibition of neutrophil elastase mediated actions (Gorrini, et al., 2001 ), a known mucus secretagogue (Dwyer and Farley, 2000) , 2) anti-inflammatory actions of macrolides (Targowski and Jahnz-Rozyk, 2008) , and 3) inhibition of release directly at the gland cell (Imamura, et al., 2004; Kaneko, et al., 2003) . The purpose of this study was to elucidate a mechanism for the direct effects of macrolides on mucus secretion and ion channels from swine SMGC. We hypothesized that macrolides interfere with calcium influx into cells to reduce secretion.
Agonist Properties
EM was shown to be a motilin receptor agonist a property responsible for gastrointestinal side effects (Yurkowski and Calis, 1992) . Irokawa et al. (1999) demonstrated that EM is a muscarinic receptor agonist.
We confirm here that EM acts as agonists at muscarinic receptors eliciting I K and I Cl and mucin release.
However, the sensitivity of swine gland cells to EM muscarinic actions is ~1000 times greater than estimated for gland cells isolated from the cat (Irokawa, et al, 1999) . The reason for this difference is unknown, but may be related to the species or the specific cell type used. EM (10 µM) increased mucin release modestly, but induced peak K Ca and Cl Ca currents similar in amplitude to those induce by a maximal concentration of ACh. In addition, EM inhibited ACh induced mucin release. Therefore, we suggest EM is a partial agonist with respect to mucus release, but a full agonist with respect to induction of peak currents.
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Inhibition of mucus release
EM slightly stimulated mucin release but inhibited mucin secretion induced by ACh (Fig. 1) at EM concentrations consistent with the estimated micromolar therapeutic tissue levels of the drugs (Jain and Danziger, 2004) . These concentrations are similar to or lower than the concentrations used by others to block mucin release in vitro (Goswami, et al., 1990; Kaneko, et al., 2003) . If EM and AZM are partial agonists at muscarinic receptors this may in part explain inhibition of ACh-induced mucus release by competitive antagonism or desensitization. However, the actions of EM and AZ are unlikely to be solely through direct receptor effects alone since mucus release induced by ACh (Fig. 1) , LPS, ovalbumin, RV14, and 3O-C(12)-HSL have all been shown to be inhibited by macrolides (Shimizu, et al., 2003; Inoue, et al., 2008; Imamura, et al., 2004) . The general nature of the inhibition suggests that there are effects of macrolides on common pathways involved in mucus release. Our data suggest a common pathway involved is inhibition of calcium influx. Secretagogue-induced mucin release occurs through exocytosis of preformed vesicles a process requiring calcium influx (Evans and Koo, 2009 ).
Non-receptor Inhibition of SMGC Function
Both Cl Ca and K Ca currents were used them as reporters of intracellular calcium levels as previously shown to be valid (Liu and Farley, 2007) . When muscarinic receptor activation by macrolides is circumvented by blocking muscarinic receptors with atropine or by applying the macrolides intracellularly, EM and AZM accelerate the decay phase of K Ca and Cl Ca currents without altering the peak responses to IP 3 (atropine protocol , Fig 4) or ACh (internal application protocol, Fig 5) . The decay phase of the currents evoked by muscarinic receptor activation were shown to be partially dependent on the influx of calcium (Liu and Farley, 2007) .. In addition, the falling phase of currents evoked by AZM and EM were significantly faster than similar amplitude ACh-induced currents, a condition that might be predicted to occur if the macrolides both activate muscarinic receptors and modify a downstream signaling event in the transduction process. We propose the signaling event downstream of receptor 1 9
activation that is inhibited is calcium influx. Using A549 cells (a human epithelial-like cell line) Zhao et al. (2000) concluded that EM blocked ATP-induced calcium influx by inhibiting P 2 X receptor channels. Kondo et al. (1998) showed that 100 µM EM applied prior to ATP induced increases in intracellular calcium in bovine epithelial cells, inhibited the sustained increase in calcium, but not the initial IP 3 -induced calcium transient, a result similar to our findings. Thus we suggest that EM and AZM inhibit calcium influx linked to muscarinic receptor activation and/or release of calcium from intracellular stores in addition to being muscarinic agonists.
Calcium Influx Pathway
Secretory epithelia in general are non-excitable and do not express voltage gated calcium channels (Petersen, 2003) . However, exocrine glands such as pancreatic acinar cells (Petersen, 2003) , salivary gland cells (Ambudkar, 2000) and sweat glands (Ko, et al., 1999) express calcium channels that are activated by second messengers or by depletion of intracellular calcium stores. We report here that calcium entry occurs after muscarinic receptor activation, intracellular IP 3 application or TG mediated intracellular calcium store depletion. Liu and Farley (2007) demonstrated that intracellular application of IP 3 induced an influx of calcium, presumably linked to release of calcium from internal stores. Kondo et al. (1998) reported a sustained calcium influx in bovine airway epithelial cells induced by P 2u receptor activation. We propose that calcium entry pathways in swine SMGC are activated by muscarinic receptors via PKC activation and/or the subsequent IP 3 -mediated calcium release from internal stores.
Canonical transient receptor potential channels (TRPC) and calcium release activated channels (CRAC,Orai1) have been implicated in store-operated calcium entry (SOC) (Lee, et al., 2010) and also via store-independent processes linked to G-protein coupled processes (ROC) (Nishida, et al., 2009 ). Both pathways may possibly be operative in SMGC since receptor activation and store depletion using TG can activate calcium influx.
This article has not been copyedited and formatted. The final version may differ from this version. As shown here (Fig 8) , the non-selective SOC and ROC inhibitors, SKF96365, 2-aminophenyl borate (2-APB), Gd +3 and La +3 (Bootman, et al., 2002; Leung, et al., 1996) all inhibit TG-induced non-selective cation current.. Liu and Farley (2007) also demonstrated that SKF96235 and 2-APB inhibit short-circuit current induced by ACh across SMGC monolayers. These findings are consistent with receptor operated and/or store operated calcium entry in swine SMGC, but does not permit further channel identification. Kondo et al. (1998) proposed that the 14, 15 membered ring macrolides (e.g., EM, AZM) may act like another macrolide FK506 (tacrolimus) an immunosuppressant drug known to inhibit calcineurin, a phosphatase, by binding to FK506 binding protein (FKBP, immunophyllin) . This inhibition ultimately blocks activation of T-lymphocytes (Morita, et al., 2006) . It has also been reported that FKBP12, one subtype of FKBP, associates with TRPC3, 6 and 7 and FKBP52 associates with TRPC1, 4, 5 (Sinkins, et al., 2004) . Sinkins et al. (2004) demonstrated that FKBP is involved in TRPC6 activation. It is intriguing to speculate that EM and AZM may interfere with calcium entry by interacting with FKBP. TG-induced calcium entry however, has generally been linked to store depletion-induced STIM1 (an ER protein) accumulation near the plasma membrane and activation of Orai1 (CRAC) channels (Putney Jr., 2007) ).
Mechanism of EM and AZM Inhibition of Calcium Entry
Our finding that EM and AZM inhibit TG-induced calcium entry is interesting, suggesting possible modulation of the STIM1-Orai1 activation pathway. However, Zhao et al. (2000) found that EM did not alter TG-induced calcium entry in A549 cells after a 20 minute pre-treatment with 100 µM EM. This difference suggests that the pathway for depletion activated calcium entry may differ depending on the cell type. It is now known that Orai1 and TRPC can form heteromeric channels (Ambudkar, et al., 2007) .
Although our data do not permit us to select between activation mechanisms, the concept that macrolides inhibit one pathway to account for both receptor-and depletion-operated calcium influx is appealing.
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It was interesting that EM and AZM inhibit of TG-induced calcium entry only slowly after the calcium entry has developed whereas inhibition of responses to TG, ACh and IP 3 require no more than five minutes pre-exposure to EM or AZM to be inhibited. Also, the currents induced by EM and AZM due to activation of muscarinic receptors decline more rapidly than do similar amplitude ACh-induced currents. This possibly is due to EM and AZM interfering with calcium influx during activation or may represent differences in receptor binding kinetics between macrolides and ACh. These findings are consistent with AZM and EM inhibiting the activation of the calcium influx pathway more readily than reversing the calcium influx once it has been activated. Further research into the activation pathway for calcium entry into SMGC needs to be performed to understand these issues. 
Conclusion
